Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation. (2018)

First Author: Tallantyre EC
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00415-018-8812-0

PubMed Identifier: 29511864

Publication URI: http://europepmc.org/abstract/MED/29511864

Type: Journal Article/Review

Volume: 265

Parent Publication: Journal of neurology

Issue: 5

ISSN: 0340-5354